A stable mutation in the clonally expanded CD8+ T cells, characterized by upregulated expression of cytotoxic gene products and molecules associated with pro-inflammatory signaling in a patient with ACPA-negative destructive RA. The gene discussed is CD8A; the disease is rheumatoid arthritis.